カタログ製品コード : C-EK22492
Mouse AXL ELISA kit
24T | ¥55,200 | (¥2,300/T) (税別) |
48T | ¥69,200 | (¥1,442/T) (税別) |
96T | ¥78,000 | (¥813/T) (税別) |
標準納期 : 2週間 |
カタログ製品コード : C-EK22492
Mouse AXL ELISA kit
24T | ¥55,200 | (¥2,300/T) (税別) |
48T | ¥69,200 | (¥1,442/T) (税別) |
96T | ¥78,000 | (¥813/T) (税別) |
標準納期 : 2週間 |
メーカー名 | 遺伝子名 | 種交差性 | 測定範囲 | サンプル量 | 適用サンプル | ドキュメント |
---|---|---|---|---|---|---|
MultiSciences | AXL | Mouse | 31.25 - 2000 pg/ml | 20 μl (prediluted) | 血清、血漿、細胞培養上清 |
■保存方法 :
キットは未開封の場合、4℃で保管すること。 開封後は標準溶液を-20℃で保存し、他の試薬は4℃で保存すること。
■構成内容 :
96-well polystyrene microplate coated with a monoclonal antibody against TNF-α |
Mouse TNF-α Standard, lyophilized |
TNF-α Detect Antibody |
Standard Diluent |
Streptavidin-HRP |
Assay Buffer (10×) |
Substrate (TMB) |
Stop Solution |
washing Buffer (20×) |
Plate Covers |
■キーワード :
Mus musculus,Mouse,Tyrosine-protein kinase receptor UFO,Adhesion-related kinase,Axl,Ark,Ufo,2.7.10.1
■ターゲット情報 :
This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of mouse AXL. The Mouse AXL ELISA is for research use only. Not for diagnostic or therapeutic procedures.
AXL receptor tyrosine kinase, together with Tyro3 and Mer, constitute the TAM family of receptor tyrosine kinases. In the nervous system, AXL and its ligand Growth-arrest-specific protein 6 (Gas6) are expressed on multiple cell types. AXL functions in dampening the immune response, regulating cytokine secretion, clearing apoptotic cells and debris, and maintaining cell survival. AXL is upregulated in various disease states, such as in the cuprizone toxicity-induced model of demyelination and in multiple sclerosis lesions, suggesting that it plays a role in disease pathogenesis. AXL expression correlates with poor prognosis in several cancers. It mediates multiple oncogenic phenotypes and activation of these RTKs constitutes a mechanism of chemoresistance in a variety of solid tumors. In addition, AXL contributes to cell survival, migration, invasion, metastasis and chemosensitivity justify further investigation of AXL as novel therapeutic targets in cancer. The soluble AXL receptor as a therapeutic candidate agent for treatment of metastatic ovarian cancer. GAS6/AXL targeting as an effective strategy for inhibition of metastatic tumor progression in vivo.